Results 21 to 30 of about 407,552 (296)

Cell death modulation by intravenous immunoglobulin [PDF]

open access: yes, 2010
The induction of cell death in immune cells by naturally occurring antibodies specific for death receptors may present an important antiinflammatory mechanism of intravenous immunoglobulin (IVIG).
Simon, Hans-Uwe   +3 more
core   +2 more sources

Intravenous immunoglobulins: a treatment for Alzheimer's disease? [PDF]

open access: yesJournal of Neurology, Neurosurgery & Psychiatry, 2004
A novel therapeutic option for Alzheimer’s disease Aβ-peptide is generally considered to play a central role in the pathogenesis of Alzheimer’s disease (AD). The peptide is cleaved from amyloid precursor protein (APP) by secretases and is a key component of the amyloid plaques.
Hack, C. E., Scheltens, P.
openaire   +2 more sources

Subcutaneous immunoglobulin in lymphoproliferative disorders and rituximab-related secondary hypogammaglobulinemia: a single-center experience in 61 patients

open access: yesHaematologica, 2014
Intravenous immunoglobulin replacement therapy represents the standard treatment for hypogammaglobulinemia secondary to B-cell lymphoproliferative disorders. Subcutaneous immunoglobulin infusion is an effective, safe and well-tolerated treatment approach
Nicolò Compagno   +3 more
doaj   +1 more source

Evaluation of high-dose aspirin elimination in the treatment of Kawasaki disease in the incidence of coronary artery aneurysm

open access: yesAnnals of Pediatric Cardiology, 2021
Background: Standard first-step therapy for Kawasaki disease consists of Intravenous immunoglobulin and high dose Aspirin (80-100 mg/kg/day). The standard dose of Intravenous immunoglobulin (2gr/kg) is strongly effective in reducing the risk of coronary ...
Farima Sanati   +3 more
doaj   +1 more source

A serious thrombotic event in a patient with immune thrombocytopenia requiring intravenous immunoglobulin: a case report

open access: yesJournal of Medical Case Reports, 2019
Background Immune thrombocytopenia is an acquired autoimmune disease. Recently, there has been evidence of thrombotic risk in patients with immune thrombocytopenia, but the mechanism is still inconclusive.
Tarinee Rungjirajittranon   +1 more
doaj   +1 more source

Intravenous Immunoglobulin Therapy-Induced Erythema Multiforme in a Patient with Chronic Lymphocytic Leukemia

open access: yesCase Reports in Dermatology, 2023
This case report discusses immunoglobulin-induced erythema multiforme (EM), a rare and understudied condition that requires further investigation. The report presents the case of a 69-year-old woman with a history of chronic lymphocytic leukemia who ...
Angelina Konovalova   +7 more
doaj   +1 more source

Serum levels of matrix metalloproteinases-2 and-9 and their tissue inhibitors in inflammatory neuromuscular disorders [PDF]

open access: yes, 2006
We monitored serum levels of matrix metalloproteinases (MMPs) and their tissue inhibitors (TIMPs) before and during intravenously applied immunoglobulin (IVIG) therapy in 33 patients with chronic immune-mediated neuropathies and myopathies and 15 ...
Mueller-Felber, W.   +3 more
core   +1 more source

Pediatric hereditary neuralgic amyotrophy: Successful treatment with intravenous immunoglobulin and insights Into SEPT9 pathogenesis

open access: yes, 2016
Hereditary neuralgic amyotrophy is a rare disorder characterized by the sudden onset of recurrent episodes of painful brachial plexus neuropathies, followed by atrophy within a few weeks.
Chuk, Raymond   +3 more
core   +1 more source

Severe aquaporin 4-IgG-positive neuromyelitis optica with disseminated herpes zoster in a pregnant woman successfully treated with intravenous immunoglobulin

open access: yesMultiple Sclerosis Journal - Experimental, Translational and Clinical, 2018
A 26-year-old, 17-week pregnant woman developed aquaporin-4-IgG-positive severe longitudinally extensive transverse myelitis during the course of disseminated herpes zoster and became quadriparetic.
Yuki Matsumoto   +7 more
doaj   +1 more source

Analysis of the sputum and inflammatory alterations of the airways in patients with common variable immunodeficiency and bronchiectasis

open access: yesClinics, 2009
INTRODUCTION: Common variable immunodeficiency is characterized by defective antibody production and recurrent pulmonary infections. Intravenous immunoglobulin is the treatment of choice, but the effects of Intravenous immunoglobulin on pulmonary defense
Andrea Cristina Pereira   +6 more
doaj   +1 more source

Home - About - Disclaimer - Privacy